Koninklijke Philips N.V. (BIT:1PHIA)

Market Cap	22.00B
Revenue (ttm)	17.86B
Net Income (ttm)	162.00M
Shares Out	n/a
EPS (ttm)	0.17
PE Ratio	135.78
Forward PE	15.32
Dividend	0.85 (3.76%)
Ex-Dividend Date	May 14, 2025

Volume	1,515
Average Volume	3,201
Open	22.86
Previous Close	22.87
Day's Range	22.59 - 22.95
52-Week Range	19.11 - 30.12
Beta	0.79
RSI	60.85
Earnings Date	Jul 29, 2025

About Ligand Pharmaceuticals

Koninklijke Philips N.V. operates as a health technology company in North America, the Greater China, and internationally. The company operates through Diagnosis & Treatment, Connected Care, and Personal Health segments. It provides diagnostic imaging solutions, includes magnetic resonance imaging; X-ray systems; and computed tomography (CT) systems and software comprising detector-based spectral CT solutions; ultrasound imaging solutions focused on diagnosis, treatment planning and guidance for cardiac, general imaging, obstetrics/gynecology, ...

• Industry: Medical Devices
• Sector: Healthcare
• Founded: 1891
• Employees: 66,678
• Stock Exchange: Borsa Italiana
• Ticker Symbol: 1PHIA

Financial Performance

In 2024, Koninklijke Philips's revenue was 18.02 billion, a decrease of -0.81% compared to the previous year's 18.17 billion. Losses were -702.00 million, 50.6% more than in 2023.